The Role of COTL1 in T cell development and activation
The Role of COTL1 in T cell development and activation
批准号:
8604682
负责人:
DANIEL D BILLADEAU
金额:
$19.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-02-01 至 2015-05-31
关键词:
ActinsAllelesAntigensB-LymphocytesBiochemicalCD28 geneCD3 AntigensCell LineCouplingCytokine SignalingCytoskeletonDefectDevelopmentDictyosteliumElementsF-ActinFailureFiberGenerationsGeneticImmigrationImmuneImmune responseInterleukin-2Knockout MiceLeukocytesLibrariesMature T-LymphocyteMediatingMolecularMovementMusMutagenesisPathway interactionsPhysiologic pulseProductionProteinsReceptor SignalingRegulationReporterRoleSignal PathwaySignal TransductionSignaling MoleculeStagingSuperantigensSynapsesSystemT-Cell ActivationT-Cell DevelopmentT-Cell ReceptorT-LymphocyteTranscription Repressor/CorepressorUp-RegulationWorkcytokinein vivoinhibitor/antagonistmigrationmutantnoveloverexpressionpolymerizationpromoterpublic health relevancesmall hairpin RNAsynaptogenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): T cell activation is central to initiating an immune response. T cell antigen receptor (TCR) engagement, in concert with costimulatory signals such as through CD28, leads to alterations in actin that control synapse formation, activation of downstream signaling pathways and cytokine production, including IL-2. To identify novel molecules that regulate T cell activation, we established a unique system coupling genetic complementation with Jurkat mutagenesis. Jurkat mutant T cell lines were generated in which TCR/CD28 stimulation failed to activate a reporter containing the RE/AP element from the IL-2 promoter. Biochemical characterization failed to pinpoint the molecular cause for the defects in T cell activation in these cell lines, implying that novel molecules or pathways were responsible. Therefore, we took a genetic approach to rescue the T cell activation defect by retroviral expression of a leukocyte library. From our initial screen, we identified one cell line in which T cell activation was restored due to overexpression of a poorly characterized protein, NKAP. Our work has demonstrated that NKAP is a transcriptional repressor that is required for T cell development and maturation, validating that this approach can identify novel proteins critical for T cell activation. Subsequently, we have identified a second molecule from this screen, COTL1 (coactosin-like protein 1). Coactosin was initially identified in Dictyostelium, as an inhibitor of
actin capping, but its function in T cells was unknown. Using shRNA knockdown, we demonstrate that COTL1 is critical for actin remodeling during T cell activation. In the absence of COTL1, Jurkat T cells fail to spread on CD3- coated coverslips or form a lamellipodia when interacting with superantigen-pulsed Raji B cells, consistent with a failure to elongate F-actin fibers. In addition, knockdown of COTL1 blocked TCR/CD28-mediated upregulation of the RE/AP element from the IL-2 promoter, demonstrating that it is required for signal transduction downstream of TCR/CD28 stimulation. Therefore, COTL1 is a novel regulator of actin remodeling and T cell activation. To understand the role of COTL1 in vivo, we have generated mice with a floxed COTL1 allele. The purpose of this R21 is to determine the function of COTL1 in T cell development, activation, F-actin remodeling and migration through the examination of COTL1 conditional knockout mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC
-
批准号:10850407
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2021
-
负责人:DANIEL D BILLADEAU
-
依托单位:
Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC
-
批准号:10593963
-
项目类别:
-
资助金额:$1.64万
-
财政年份:2021
-
负责人:DANIEL D BILLADEAU
-
依托单位:
Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC
-
批准号:10095909
-
项目类别:
-
资助金额:$32.97万
-
财政年份:2021
-
负责人:DANIEL D BILLADEAU
-
依托单位:
Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC
-
批准号:10378472
-
项目类别:
-
资助金额:$32.31万
-
财政年份:2021
-
负责人:DANIEL D BILLADEAU
-
依托单位:
NIDDK Multidisciplinary Predoctoral Training in Discovery and Translational Research
-
批准号:10392357
-
项目类别:
-
资助金额:$20.91万
-
财政年份:2020
-
负责人:DANIEL D BILLADEAU
-
依托单位:
NIDDK Multidisciplinary Predoctoral Training in Discovery and Translational Research
-
批准号:10612790
-
项目类别:
-
资助金额:$20.43万
-
财政年份:2020
-
负责人:DANIEL D BILLADEAU
-
依托单位:
Mechanisms Regulating Human NK Cell Cytotoxicity
-
批准号:9274925
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2016
-
负责人:DANIEL D BILLADEAU
-
依托单位:
Mechanisms Regulating Human NK Cell Cytotoxicity
-
批准号:9919370
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2016
-
负责人:DANIEL D BILLADEAU
-
依托单位:
Regulation of Nutrient Homeostasis by COMMD proteins
-
批准号:10579910
-
项目类别:
-
资助金额:$43.41万
-
财政年份:2016
-
负责人:DANIEL D BILLADEAU
-
依托单位:
Regulation of Nutrient Homeostasis by COMMD proteins
-
批准号:10394205
-
项目类别:
-
资助金额:$43.93万
-
财政年份:2016
-
负责人:DANIEL D BILLADEAU
-
依托单位:
Regulation of Copper Homeostasis by COMMD proteins
-
批准号:9316602
-
项目类别:
-
资助金额:$43.5万
-
财政年份:2016
-
负责人:DANIEL D BILLADEAU
-
依托单位:
Mayo Clinic SPORE in Pancreatic Cancer
-
批准号:9331422
-
项目类别:
-
资助金额:$230.0万
-
财政年份:2014
-
负责人:DANIEL D BILLADEAU
-
依托单位:
Regulation of NK Cell Activation by DOCK8-Mediated Pathways
-
批准号:8892294
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2014
-
负责人:DANIEL D BILLADEAU
-
依托单位:
NFAT Transcription Factors as Therapeutic Targets in Pancreatic Cancer
-
批准号:8738911
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2014
-
负责人:DANIEL D BILLADEAU
-
依托单位:
Mayo Clinic SPORE in Pancreatic Cancer
-
批准号:9127935
-
项目类别:
-
资助金额:$215.77万
-
财政年份:2014
-
负责人:DANIEL D BILLADEAU
-
依托单位:
P-1: Regulation of Pancreatic Cancer Cell Production and Survival by GSK-3B
-
批准号:8719560
-
项目类别:
-
资助金额:$12.8万
-
财政年份:2013
-
负责人:DANIEL D BILLADEAU
-
依托单位:
The Role of COTL1 in T cell development and activation
-
批准号:8458811
-
项目类别:
-
资助金额:$23.85万
-
财政年份:2013
-
负责人:DANIEL D BILLADEAU
-
依托单位:
P-1: Regulation of Pancreatic Cancer Cell Production and Survival by GSK-3B
-
批准号:7510757
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2008
-
负责人:DANIEL D BILLADEAU
-
依托单位:
Regulation of Actin Dynamics During T Cell Activation
-
批准号:6955283
-
项目类别:
-
资助金额:$25.33万
-
财政年份:2005
-
负责人:DANIEL D BILLADEAU
-
依托单位:
Regulation of Actin Dynamics During T Cell Activation
-
批准号:7092231
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2005
-
负责人:DANIEL D BILLADEAU
-
依托单位:
海外基金